No Data
No Data
AI hotspots continue to boost! Most Medical stocks in Hong Kong strengthen, with Micro-invasion Siasun Robot&Automation rising over 20%.
How does Sister Wood perceive this hot topic of AI Medical? What positive impacts will the emergence of DeepSeek bring to the medical field?
Xinwei Medical-B (06609.HK) has received a Shareholding increase of 1.235 million Listed in Hong Kong shares from Wisary Limited and related parties, valued at approximately 22.7119 million Hong Kong dollars.
On January 23, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on January 23, Wisary Limited increased its shareholding in $心玮医疗-B(06609.HK)$ by 1.235 million H-shares at an average price of HKD 18.39 per share on January 17, worth approximately HKD 22.7119 million. After the increase, Wisary Limited's latest number of shares held is 2.8358 million shares, raising the shareholding ratio from 5.07% to 8.98%. Source of the image: Stock disclosure from the stock exchange (part of the table for this event). What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders...
Hong Kong stock Concept tracking | Local policies intensify layout of Brain-computer Interface Industry commercialization process accelerates (with Concept stocks)
At the beginning of the year, Peking and Shanghai released action plans, providing clear development directions regarding regulatory policies, clinical trials, industrial clusters, commercialization, and the Industry Chain in the Brain-computer Interface field.
Express News | China International Capital Corporation: The medical instruments Sector is expected to benefit from product upgrades and overseas exports in 2025.
Hong Kong stock concept tracking | The first patient in Shanghai to receive a Brain-computer Interface implant "can now drink water controlled by the brain". There are more clinical trials of domestic Brain-computer Interfaces. (Included concept stocks)
Next year, China will carry out 30 to 50 clinical trial implantation surgeries for domestic Brain-computer Interfaces.
Innovation genes stimulate intrinsic motivation, Xinwei Medical-B (6609.HK) was awarded the 'Annual Innovation Award'.
Innovation is undoubtedly the lifeblood of a company's survival and development. In today's rapidly changing business environment, companies must continuously innovate to maintain competitiveness and achieve self-breakthroughs. As Darwin said, "It is not the strongest species that survive, nor the most intelligent, but the most responsive to change." Therefore, how companies strengthen their core competitiveness, continuously enhance their technology capabilities around innovation, lead industry development, and even promote industrial revolutions will become the key to standing out. Recently, at the "Gelonghui · Global Investment Carnival · 2025" event, Xinwei Medical was awarded the "Annual Innovation Award," highlighting its.